| Date |
Topic Covered |
View PDF |
| July 2009 |
Glucose tolerance abnormalities and type 2 diabetes in youth: New developments |
 |
| July 2009 |
G-protein–coupled receptors in the pancreatic islets may be targets for treatment of type 2 diabetes |
|
| 2009 |
Coronary and cardiovascular mortality in type 2 diabetic patients treated with the sulfonylurea-metformin combination: the type of sulfonylurea is pivotal |
|
| 2009 |
New interesting date on obesity genetics |
|
| 2009 |
Diabetic vascular disease and aspirin: no effect in primary prevention |
|
| 22nd April 2009 |
Role of the gut microbiome in metabolic health: are bacteria in part to blame for human obesity? |
|
| 2008 |
Oxidative stress and atherosclerosis |
|
| 2008 |
Better prognosis for diabetic foot syndrome-good news in 2008 |
|
| 2008 |
Rapamycin (sirolimus), B-cell mass, B-cell function, and insulin action |
|
| 2008 |
Nephropathy in type 2 diabetes mellitus: further implications for the benefits of intensive glucose control in the advance trial |
|
| 21st October 2008 |
Genetic approaches to the metabolic syndrome |
|
| 14th October 2008 |
ADMA, cardiovascular disease, and diabetes |
|
| 7th October 2008 |
The DESG Awards-supporting research in Therapeutic Patient Education |
|
| July 2008 |
Intensive glycemic control arm of accord stopped prematurely |
|
